Health-care ETFs
IBB vs IYH.
iShares Biotechnology ETF (NYSE Biotechnology) against iShares U.S. Healthcare ETF (Russell 1000 Health Care RIC 22.5/45 Capped) — fees, long-horizon total returns, holdings overlap, and sector tilt, side by side.
Performance · total return
Daily bar history for this pair isn’t loaded yet — returns will appear once the nightly ingest covers both funds.
Fund facts
| IBB | IYH | |
|---|---|---|
| Name | iShares Biotechnology ETF | iShares U.S. Healthcare ETF |
| Category | Health | Health |
| Style | Passive | Passive |
| Expense ratio | 0.45% | — |
| Assets (AUM) | $9.1B | $3.2B |
| Dividend yield | 0.22% | 1.19% |
| Avg volume (3-mo) | 1.6M | 741K |
| Inception | February 5, 2001 | June 12, 2000 |
| Benchmark proxy | S&P 500 | S&P 500 |
Expense ratios verified against issuer fact sheets. Dividend yield is trailing 12-month distributions divided by price, as reported by the fund data provider.
Holdings overlaptop-25 holdings · coverage IBB 44.7% · IYH 59.5%
5.9%of portfolio weight overlaps2 shared of top 10
| Shared holding | IBB | IYH | MIN |
|---|---|---|---|
| AMGNAmgen Inc | 7.82% | 3.28% | 3.28% |
| GILDGilead Sciences Inc | 6.83% | 2.63% | 2.63% |
Sum of min(weight in each fund) across shared tickers — the standard fund-overlap measure. Computed on the top 25 holdings each fund reports, so it is a lower bound; the coverage figures show how much of each fund those top holdings represent.
Sector tilt IBB IYH
Healthcare100.0% / 100.0%+0.0pp
More health-care etfs
ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comreturn history unavailable · fund facts · issuer-verified · holdings · fund data provider
Compare any two funds in ALAN
The interactive tool takes any pair, adds total-vs-price toggles, and saves comparisons to your workspace.
For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.